NEW YORK, Jan. 13, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
This analysis examines the historical and forecast performance for CSL in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits
* Gain insight into CSL's strategic outlook across the next 6 years* Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source
Strategic insight into the prospects for CSL over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.
Your key questions answered
* Benchmark CSL's performance against key rivals in the prescription pharmaceutical sector* Assess the importance of the recently launched Hizentra to CSL's topline growth over the forecast period
To order this report:
Intl: +1 805-652-2626
Copyright©2010 PR Newswire.
All rights reserved